Experiencia con vismodegib en carcinoma basocelular avanzado en un centro oncológico-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Experiencia con vismodegib en carcinoma basocelular avanzado en un centro oncológico

Published:2018-11 Issue:9 Volume:109 Page:813-820
ISSN:0001-7310
Container-title:Actas Dermo-Sifiliográficas
language:es
Short-container-title:Actas Dermo-Sifiliográficas

Author:

Bernia E.,Llombart B.,Serra-Guillén C.,Bancalari B.,Nagore E.,Requena C.,Calomarde L.,Diago A.,Lavernia J.,Traves V.,Guillén C.,Sanmartín O.

Publisher

Elsevier BV

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Reference18 articles.

1. Efficacy and safety of vismodegib in advanced basal-cell carcinoma;Sekulic;N Engl J Med.,2012

2. Incidencia y mortalidad del cáncer cutáneo en España: revisión sistemática y metaanálisis;Tejera-Vaquerizo;Actas Dermosifiliogr.,2016

3. Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study;Goldenberg;J Am Acad Dermatol.,2016

4. The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer;Warner;Am J Clin Dermatol.,2011

5. Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease;McCusker;Eur J Cancer.,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Periocular Basal Cell Carcinoma with Orbital Invasion: Update on Management and Treatment Advances;Journal of Ophthalmology;2024-02-29

2. Retrospective Real-Life Data, Efficacy and Safety of Vismodegib Treatment in Patients with Advanced and Multiple Basal Cell Carcinoma: 3-Year Experience from a Spanish Center;International Journal of Environmental Research and Public Health;2023-05-15

3. Treatment of locally advanced basal cell carcinoma with vismodegib;Medicina Clínica (English Edition);2023-05

4. Vismodegib en el tratamiento del carcinoma basocelular localmente avanzado;Medicina Clínica;2023-05

5. Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia;Dermatology;2022-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3